Treatment Outcome in Elderly Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
A multicenter randomized trial evaluating the possible benefit of androgens during post remission therapy in an attempt to improve the outcome of AML in older patients.All patients received the ICL regimen as induction and were randomized to receive, after achieving CR or PR, a maintenance therapy including or not androgens. Patients randomized with androgens additionally received 10 to 20 mg according to body weigh of norethandrolone daily for up to 2 years
Epistemonikos ID: 6df36e5394aa3dfb59899a37e0ea4de39f218540
First added on: May 05, 2024